May & Baker, a listed pharmaceutical company, has reported N1.1 billion in profit for the first quarter of 2025, a 74 percent increase from the N655 million reported in the same period of the previous year. According to BusinessDay’s analysis of the company’s Q1 financial results, the com
```
Members Only

Login or create an account to continue

This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.

New to BusinessDay? Register now and start reading.

```

Join BusinessDay whatsapp Channel, to stay up to date

Open In Whatsapp